Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Automated Cell Culture Equipment Market Size

ID: MRFR/MED/7298-CR
115 Pages
Vikita Thakur
Last Updated: January 30, 2026

Automated Cell Culture Equipment Market Research Report Information by Lab Automation Type (Modular Automation and Whole Lab Automation), by Product Type (Consumables, Equipment and Software), Application (Biopharmaceutical Production, Tissue Engineering, Vaccine Production, Gene Therapy & Regenerative Medicine, Stem Cell Therapy, Toxicity Testing and Diagnostics), End User (Pharmaceutical & Biotechnology Companies, Research and Academic Institutes and Hospitals and Diagnostic Laboratories) - Forecast till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Automated Cell Culture Equipment Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Automated Cell Culture Equipment Size

Automated Cell Culture Equipment Market Growth Projections and Opportunities

The Global Regenerative Medicine Market is on a steady rise, and several key factors contribute to its growth. One significant driver is the continuous advancement in healthcare technology. As technology in the healthcare sector continues to evolve, it plays a pivotal role in enhancing regenerative medicine, contributing to the market's expansion.

Another influential factor is the ongoing progress in regenerative medicine technology. Innovations in this field have a direct impact on the market's development, driving the adoption of cutting-edge techniques and therapies. This constant evolution in regenerative medicine technology propels the market forward, creating new opportunities and expanding its scope.

The rising prevalence of chronic diseases is also a major catalyst for the growth of the regenerative medicine market. With an increasing number of people worldwide being affected by chronic health conditions, there is a growing demand for advanced and effective treatment options. Regenerative medicine offers promising solutions for managing and treating various chronic diseases, making it a key player in addressing global health challenges.

Additionally, the growth in stem cell technology contributes significantly to the expansion of the regenerative medicine market. Stem cells have unique properties that make them valuable in medical research and therapeutic applications. The continuous progress in stem cell technology opens up possibilities for novel treatments and interventions, fostering the market's development.

Globally, the regenerative medicine market is projected to experience a robust growth rate of approximately 21.18% from 2021 to 2027. This optimistic outlook indicates a promising trajectory for the market, with numerous opportunities for stakeholders, researchers, and healthcare providers.

The increasing awareness and acceptance of regenerative medicine further fuel its market growth. As knowledge about the benefits and potential applications of regenerative therapies spreads, there is a growing acceptance among both healthcare professionals and the general public. This acceptance contributes to the wider adoption of regenerative medicine approaches, driving market expansion.

Collaborations and partnerships within the healthcare industry also play a crucial role in advancing regenerative medicine. The synergy between different stakeholders, including pharmaceutical companies, research institutions, and healthcare providers, fosters innovation and accelerates the development of regenerative therapies. These collaborative efforts contribute to the overall growth and success of the regenerative medicine market.

Moreover, regulatory support and favorable government initiatives contribute to the market's positive momentum. As governments recognize the significance of regenerative medicine in addressing healthcare challenges, they are increasingly providing support through regulatory frameworks and funding. This support creates a conducive environment for research and development in regenerative medicine, bolstering the market's progress.

Automated Cell Culture Equipment Market Size Graph
Author
Author Profile
Vikita Thakur
Senior Research Analyst

She holds an experience of about 5+ years in market research and business consulting projects for sectors such as life sciences, medical devices, and healthcare IT. She possesses a robust background in data analysis, market estimation, competitive intelligence, pipeline analysis market trend identification, and consumer behavior insights. Her expertise lies in technical Sales support, client interaction and project management, designing and implementing market research studies, conducting competitive analysis, and synthesizing complex data into actionable recommendations that drive business growth.

Get In Touch

Leave a Comment

FAQs

What is the projected market valuation of the Automated Cell Culture Equipment Market by 2035?

<p>The market is projected to reach approximately 2.121 USD Billion by 2035.</p>

What was the market valuation of the Automated Cell Culture Equipment Market in 2024?

<p>The market valuation was 0.97 USD Billion in 2024.</p>

What is the expected CAGR for the Automated Cell Culture Equipment Market from 2025 to 2035?

<p>The expected CAGR during the forecast period 2025 - 2035 is 7.37%.</p>

Which segment is anticipated to have the highest growth in the Automated Cell Culture Equipment Market?

<p>The Modular Automation segment is expected to grow from 0.58 USD Billion in 2024 to 1.23 USD Billion by 2035.</p>

What are the key product types in the Automated Cell Culture Equipment Market?

<p>Key product types include Consumables, Equipment, and Software, with Equipment projected to grow from 0.45 USD Billion to 1.0 USD Billion by 2035.</p>

Which end-user segment is likely to dominate the Automated Cell Culture Equipment Market?

<p>The Pharmaceutical and Biotechnological Industries are projected to dominate, growing from 0.45 USD Billion in 2024 to 0.95 USD Billion by 2035.</p>

Who are the leading companies in the Automated Cell Culture Equipment Market?

<p>Key players include Thermo Fisher Scientific, Merck KGaA, Corning Incorporated, and Becton, Dickinson and Company.</p>

What applications are driving growth in the Automated Cell Culture Equipment Market?

Applications such as Biopharmaceutical Productions and Vaccine Production are driving growth, with the former expected to rise from 0.25 USD Billion to 0.55 USD Billion by 2035.

How does the Whole Lab Automation segment compare to Modular Automation in terms of market size?

The Whole Lab Automation segment is projected to grow from 0.39 USD Billion in 2024 to 0.89 USD Billion by 2035, indicating substantial growth but less than Modular Automation.

What is the significance of the Automated Cell Culture Equipment Market for research and academic institutes?

Research and Academic Institutes are expected to see growth from 0.12 USD Billion in 2024 to 0.25 USD Billion by 2035, highlighting their increasing reliance on automated solutions.

Market Summary

As per Market Research Future analysis, the Automated Cell Culture Equipment Market was estimated at 0.97 USD Billion in 2024. The Automated Cell Culture Equipment industry is projected to grow from 1.041 USD Billion in 2025 to 2.121 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.37% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Automated Cell Culture Equipment Market is poised for substantial growth driven by technological advancements and increasing demand for biopharmaceuticals.

  • Technological advancements are enhancing the efficiency and precision of automated cell culture processes. North America remains the largest market, while Asia-Pacific is emerging as the fastest-growing region in this sector. The modular automation segment leads the market, whereas whole lab automation is experiencing rapid growth. Rising demand for biopharmaceuticals and increased focus on research and development are key drivers propelling market expansion.

Market Size & Forecast

2024 Market Size 0.97 (USD Billion)
2035 Market Size 2.121 (USD Billion)
CAGR (2025 - 2035) 7.37%
Largest Regional Market Share in 2024 America

Major Players

Thermo Fisher Scientific (US), Merck KGaA (DE), Corning Incorporated (US), Becton, Dickinson and Company (US), Lonza Group AG (CH), GE Healthcare (US), Sartorius AG (DE), Eppendorf AG (DE), Fujifilm Irvine Scientific (US)

Market Trends

The Automated Cell Culture Equipment Market is currently experiencing a notable transformation, driven by advancements in technology and increasing demand for efficient laboratory processes. This market encompasses a wide range of equipment designed to facilitate the growth and maintenance of cells in controlled environments. As research institutions and biotechnology companies seek to enhance productivity and reproducibility in their experiments, the adoption of automated solutions appears to be on the rise. Furthermore, the integration of artificial intelligence and machine learning into these systems suggests a potential for improved data analysis and decision-making in cell culture practices.

In addition to technological advancements, the growing emphasis on personalized medicine and regenerative therapies is likely to propel the Automated Cell Culture Equipment Market forward. Researchers are increasingly focused on developing tailored treatments, which necessitates sophisticated cell culture techniques. This trend indicates a shift towards more specialized equipment that can accommodate diverse cell types and experimental conditions.

As the market evolves, it may also witness a surge in collaborations between equipment manufacturers and research institutions, fostering innovation and expanding the range of available solutions. Overall, the future of the Automated Cell Culture Equipment Market appears promising, with numerous opportunities for growth and development.

Technological Advancements

The Automated Cell Culture Equipment Market is witnessing rapid technological advancements, particularly in automation and robotics. These innovations enhance precision and efficiency in cell culture processes, allowing researchers to focus on more complex tasks.

Personalized Medicine

The increasing focus on personalized medicine is shaping the Automated Cell Culture Equipment Market. As therapies become more tailored to individual patient needs, the demand for specialized equipment that can support diverse cell types is likely to grow.

Collaborative Innovations

Collaborations between equipment manufacturers and research institutions are becoming more prevalent in the Automated Cell Culture Equipment Market. Such partnerships foster innovation, leading to the development of cutting-edge solutions that address specific research challenges.

Automated Cell Culture Equipment Market Market Drivers

Rising Demand for Biopharmaceuticals

The increasing demand for biopharmaceuticals is a primary driver of the Automated Cell Culture Equipment Market. As the healthcare sector continues to evolve, the need for advanced therapies, including monoclonal antibodies and cell-based therapies, has surged. This trend is supported by data indicating that the biopharmaceutical market is projected to reach approximately USD 500 billion by 2025. Consequently, the Automated Cell Culture Equipment Market is experiencing heightened demand as these technologies are essential for the production and development of biopharmaceuticals. The efficiency and scalability offered by automated systems are likely to enhance productivity, thereby meeting the growing needs of the biopharmaceutical sector.

Technological Innovations in Automation

Technological innovations in automation are reshaping the landscape of the Automated Cell Culture Equipment Market. Advancements in robotics, artificial intelligence, and machine learning are enhancing the capabilities of automated systems, making them more efficient and user-friendly. For instance, the integration of AI in cell culture processes allows for real-time monitoring and optimization, which can lead to improved outcomes. The market for automated cell culture equipment is projected to grow at a compound annual growth rate (CAGR) of around 10% through 2025, driven by these technological advancements. As laboratories increasingly adopt these innovations, the Automated Cell Culture Equipment Market is poised for substantial growth.

Increased Focus on Research and Development

The emphasis on research and development (R&D) in the life sciences sector significantly propels the Automated Cell Culture Equipment Market. With a growing number of research institutions and pharmaceutical companies investing in R&D, the demand for sophisticated cell culture technologies is on the rise. Reports suggest that R&D spending in the life sciences is expected to exceed USD 200 billion by 2025. This investment is likely to drive the adoption of automated cell culture systems, which facilitate high-throughput screening and reproducibility in experiments. As researchers seek to accelerate their findings, the Automated Cell Culture Equipment Market stands to benefit from this trend.

Growing Adoption of 3D Cell Culture Techniques

The growing adoption of 3D cell culture techniques is a notable driver of the Automated Cell Culture Equipment Market. Unlike traditional 2D cultures, 3D cell cultures provide a more accurate representation of in vivo environments, leading to better predictive models for drug testing and disease research. This shift towards 3D methodologies is supported by a market analysis indicating that the 3D cell culture market is expected to reach USD 2 billion by 2025. As researchers and pharmaceutical companies recognize the advantages of 3D cultures, the demand for automated systems that can support these techniques is likely to increase, thereby benefiting the Automated Cell Culture Equipment Market.

Regulatory Support for Advanced Cell Culture Technologies

Regulatory support for advanced cell culture technologies is increasingly influencing the Automated Cell Culture Equipment Market. Regulatory bodies are recognizing the importance of innovative cell culture methods in drug development and safety testing. This support is evident in the establishment of guidelines that encourage the use of automated systems to enhance reproducibility and reduce variability in experiments. As regulatory frameworks evolve to accommodate these advancements, the market for automated cell culture equipment is expected to expand. The alignment of regulatory policies with technological progress may foster greater adoption of automated solutions, thereby driving growth in the Automated Cell Culture Equipment Market.

Market Segment Insights

By Lab Automation Type: Modular Automation (Largest) vs. Whole Lab Automation (Fastest-Growing)

The Automated Cell Culture Equipment Market showcases a diverse range of lab automation types, with Modular Automation holding the largest market share. This segment caters to laboratories that prefer flexibility and scalability in their automation solutions. Whole Lab Automation, although comparatively smaller, is gaining traction as it offers an integrated workflow solution that appeals to high-throughput research environments. As labs aim for enhanced efficiency, Modular Automation is favored, yet Whole Lab Automation is poised for significant growth as research demands increase.

Lab Automation Type: Modular Automation (Dominant) vs. Whole Lab Automation (Emerging)

Modular Automation is characterized by its flexibility, allowing laboratories to customize their automation setup according to evolving research needs. It facilitates incremental investments, enabling labs to start small and upscale gradually. This adaptability makes it a dominant choice for many facilities prioritizing cost-control and efficiency. On the other hand, Whole Lab Automation represents the emerging trend in the market. It integrates various lab functions into a seamless workflow, providing robust solutions particularly suited for high-throughput applications. As labs strive for optimization, Whole Lab Automation is becoming increasingly attractive, drawing attention for its potential to revolutionize lab operations and enhance productivity.

By Product Type: Consumables (Largest) vs. Equipment (Fastest-Growing)

In the Automated Cell Culture Equipment Market, the product type segment is primarily dominated by consumables, which play a pivotal role in the overall market share distribution. This segment includes essential items like media, reagents, and plates that are critical for cell culture processes. Equipment, while a significant contributor, is witnessing rapid growth as laboratories increasingly invest in advanced technology to enhance efficiency and precision in cell cultures. On the other hand, the equipment segment is gaining momentum, driven by innovations that provide enhanced capabilities and ease of use. The demand for automated solutions, particularly amid a growing emphasis on high-throughput applications, is accelerating this trend. Moreover, the continuous advancements in lab automation technology and an increase in funding for biotech research are poised to further bolster growth in this segment over the coming years.

Consumables (Dominant) vs. Software (Emerging)

In the context of the Automated Cell Culture Equipment Market, consumables remain the dominant component, accounting for a substantial share of the overall market. This dominance is attributed to the necessity of consumables in every cell culture experiment, ensuring the successful growth and analysis of cells. On the other hand, software is emerging as a critical support system, providing enhanced data management capabilities and integration with automated equipment. The trend towards digitization in laboratories is accelerating the adoption of sophisticated software solutions aimed at streamlining workflows and improving data accuracy. While consumables are essential for operations, software is increasingly recognized for its potential to transform data into actionable insights, driving innovations in experimental design and execution.

By Application: Biopharmaceutical Productions (Largest) vs. Vaccine Production (Fastest-Growing)

The Automated Cell Culture Equipment Market is primarily driven by the application in biopharmaceutical productions, which holds a significant portion of the overall market share. This sector benefits from the increasing demand for biologics and the shift toward innovative therapies. Vaccine production is emerging as a crucial segment, currently witnessing rapid growth due to surging public health initiatives and the need for rapid response to pandemics, leading to increased investments in this area.

Application: Biopharmaceutical Productions (Dominant) vs. Vaccine Production (Emerging)

In the Automated Cell Culture Equipment Market, biopharmaceutical productions dominate due to the rising prevalence of chronic diseases and the consequent demand for biopharmaceutical drugs. This segment showcases advanced technological integration and robust production capabilities, focusing on high-quality outputs. Conversely, vaccine production represents an emerging area fueled by heightened awareness and urgency surrounding vaccine development, especially in light of global health challenges. This segment is characterized by innovative technologies like continuous cell culture processes and automated solutions that enhance efficiency and scalability, positioning it as a key growth driver within the market.

By End-User: Pharmaceutical and Biotechnological Industries (Largest) vs. Research and Academic Institutes (Fastest-Growing)

In the Automated Cell Culture Equipment Market, the end-user segment is largely dominated by the Pharmaceutical and Biotechnological Industries, which hold the largest market share due to their extensive research and development programs. These industries rely heavily on automated cell culture technologies to expedite drug discovery and production processes. Following closely are Hospitals and Diagnostic Labs, and Pathological Labs, which play essential roles in clinical research and diagnostics. While these segments contribute significantly, Research and Academic Institutes are emerging as a fast-growing segment owing to increased funding for scientific studies and innovative research methodologies. Growth trends indicate a shift towards automation in cell culture practices driven by the need for efficiency and reproducibility in biological research. Pharmaceutical and Biotechnological Industries will continue to invest in advanced technologies, enhancing their operational efficiencies and research outputs. Meanwhile, Research and Academic Institutes are increasingly adopting automated cell culture solutions to facilitate high-throughput screening and more efficient research workflows, positioning them as critical players in the future of the market.

Pharmaceutical and Biotechnological Industries (Dominant) vs. Research and Academic Institutes (Emerging)

The Pharmaceutical and Biotechnological Industries segment stands out as the dominant user of automated cell culture equipment, primarily due to their relentless pursuit of innovation in drug development and cellular therapies. This segment is characterized by substantial investments in R&amp;D and a consistent drive towards improving production efficiency and reliability in cell-based assays. On the other hand, Research and Academic Institutes are emerging rapidly in this market, driven by increased grants for research and a growing emphasis on translational science. These institutes are deploying automated systems to enhance productivity in experiments and streamline workflows, thereby encouraging collaborative research and rapid advancements in cell biology and regenerative medicine.

Get more detailed insights about Automated Cell Culture Equipment Market Research Report - Forecast till 2035

Regional Insights

North America : Innovation and Investment Hub

North America is the largest market for automated cell culture equipment, holding approximately 45% of the global market share. The region's growth is driven by significant investments in biotechnology and pharmaceuticals, alongside a robust regulatory framework that encourages innovation. The increasing demand for personalized medicine and advanced therapies further propels market expansion, with a focus on automation to enhance efficiency and reduce costs. The United States is the leading country in this region, home to major players like Thermo Fisher Scientific and GE Healthcare. The competitive landscape is characterized by continuous technological advancements and strategic partnerships among key players. Canada also plays a significant role, contributing to the market with its growing biotech sector and research initiatives, fostering a collaborative environment for innovation.

Europe : Regulatory Framework and Growth

Europe is the second-largest market for automated cell culture equipment, accounting for approximately 30% of the global market share. The region benefits from stringent regulatory standards that ensure product quality and safety, driving demand for advanced automated solutions. The increasing focus on regenerative medicine and cell-based therapies is a key growth driver, supported by government initiatives promoting research and development in biotechnology. Germany and the United Kingdom are the leading countries in this market, with a strong presence of key players like Merck KGaA and Sartorius AG. The competitive landscape is marked by innovation and collaboration among industry stakeholders, including academic institutions and research organizations. The European market is poised for growth, with ongoing investments in automation technologies and a favorable regulatory environment that encourages market entry and expansion.

Asia-Pacific : Rapid Growth and Adoption

Asia-Pacific is witnessing rapid growth in the automated cell culture equipment market, holding approximately 20% of the global market share. The region's expansion is fueled by increasing investments in healthcare infrastructure and a rising demand for biopharmaceuticals. Countries like China and India are at the forefront, driven by government initiatives to boost research and development in biotechnology and pharmaceuticals, alongside a growing population that demands advanced healthcare solutions. China is the largest market in the region, with significant contributions from local manufacturers and international players. The competitive landscape is evolving, with a mix of established companies and startups focusing on innovation. India is also emerging as a key player, leveraging its skilled workforce and cost-effective production capabilities to attract investments in automated cell culture technologies, further enhancing the region's market potential.

Middle East and Africa : Untapped Market Potential

The Middle East and Africa region is gradually emerging in the automated cell culture equipment market, currently holding about 5% of the global market share. The growth is driven by increasing investments in healthcare and biotechnology sectors, alongside a rising awareness of the benefits of automation in laboratory processes. Countries like South Africa and the UAE are leading the way, with government initiatives aimed at enhancing research capabilities and healthcare infrastructure. South Africa is the most developed market in the region, with a growing number of research institutions and biotech companies. The competitive landscape is characterized by a mix of local and international players, focusing on expanding their presence in this untapped market. The region's potential for growth is significant, as more stakeholders recognize the importance of automated solutions in improving research efficiency and outcomes.

Key Players and Competitive Insights

The Automated Cell Culture Equipment Market is currently characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for efficient cell culture processes. Key players such as Thermo Fisher Scientific (US), Merck KGaA (DE), and Sartorius AG (DE) are strategically positioned to leverage innovation and expand their market presence. Thermo Fisher Scientific (US) focuses on enhancing its product portfolio through continuous innovation, while Merck KGaA (DE) emphasizes strategic partnerships to bolster its research capabilities. Sartorius AG (DE) is actively pursuing digital transformation initiatives, which collectively shape a competitive environment that prioritizes technological superiority and operational efficiency.

In terms of business tactics, companies are increasingly localizing manufacturing to reduce lead times and optimize supply chains. The market appears moderately fragmented, with several key players exerting influence over specific segments. This fragmentation allows for niche players to thrive, while larger companies consolidate their positions through strategic acquisitions and partnerships, thereby enhancing their competitive edge.

In August 2025, Thermo Fisher Scientific (US) announced the launch of a new automated cell culture platform designed to streamline workflows and improve reproducibility in research settings. This innovation is expected to significantly enhance laboratory efficiency, positioning the company as a leader in the automation of cell culture processes. The strategic importance of this launch lies in its potential to attract a broader customer base seeking advanced solutions in cell culture technology.

In September 2025, Merck KGaA (DE) entered into a collaboration with a leading biotechnology firm to develop next-generation cell culture media. This partnership aims to enhance the performance of cell cultures, thereby addressing the growing demand for high-quality cell culture products. The collaboration underscores Merck's commitment to innovation and its strategy to remain at the forefront of the market by leveraging external expertise.

In July 2025, Sartorius AG (DE) unveiled a new digital platform that integrates artificial intelligence to optimize cell culture processes. This platform is designed to provide real-time analytics and predictive insights, which could revolutionize how researchers approach cell culture. The introduction of AI into their offerings reflects Sartorius's forward-thinking strategy and its focus on digital transformation, which is becoming increasingly vital in the competitive landscape.

As of October 2025, current trends in the Automated Cell Culture Equipment Market indicate a strong emphasis on digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are playing a crucial role in shaping the competitive landscape, as companies seek to combine resources and expertise to drive innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, innovative solutions, and reliable supply chains, thereby redefining the parameters of success in this rapidly evolving market.

Key Companies in the Automated Cell Culture Equipment Market include

Industry Developments

Various developments are seen in the automated cell culture equipment market which is as follows:

    • In the year 2020, a japan based biotechnical organization named ThinkCyte Inc., came in a joint venture with Hitachi to develop an artificial intelligence system for strengthening cell analysis.
    • In the year 2019, Thermo Fisher introduced a new automated incubator for delivering and maintaining cells and microorganisms in a controlled environment.
    • In June of 2020, ThermoGnesis Corp., a pharmaceutical company, launched an X-series cell culturing products at a commercial level.
    • In May of 2019, Sartorius AG brought into being an automated micro-bioreactor, called Ambr 15 Cell Culture.
    • In the year 2020, HORIBA Medical and CellaVision collaborated and produced an automated digital cell morphology solution. 

 

Future Outlook

Automated Cell Culture Equipment Market Future Outlook

The Automated Cell Culture Equipment Market is projected to grow at a 7.37% CAGR from 2025 to 2035, driven by advancements in biotechnology, increasing demand for personalized medicine, and automation in laboratory processes.

New opportunities lie in:

  • <p>Development of integrated automated cell culture systems for high-throughput applications. Expansion into emerging markets with tailored solutions for local research needs. Partnerships with biotech firms to co-develop specialized cell culture technologies.</p>

By 2035, the market is expected to be robust, reflecting substantial growth and innovation.

Market Segmentation

Automated Cell Culture Equipment Market End-User Outlook

  • Pharmaceutical and Biotechnological Industries
  • Hospitals and Diagnostic Labs
  • Pathological Labs
  • Research and Academic Institutes

Automated Cell Culture Equipment Market Application Outlook

  • Biopharmaceutical Productions
  • Vaccine Production
  • Tissue Engineering
  • Stem Cell Therapy
  • Toxicity Testing
  • General Diagnosis
  • Drug Screening and Development

Automated Cell Culture Equipment Market Product Type Outlook

  • Consumables
  • Equipment
  • Software

Automated Cell Culture Equipment Market Lab Automation Type Outlook

  • Modular Automation
  • Whole Lab Automation

Report Scope

MARKET SIZE 2024 0.97(USD Billion)
MARKET SIZE 2025 1.041(USD Billion)
MARKET SIZE 2035 2.121(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 7.37% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Thermo Fisher Scientific (US), Merck KGaA (DE), Corning Incorporated (US), Becton, Dickinson and Company (US), Lonza Group AG (CH), GE Healthcare (US), Sartorius AG (DE), Eppendorf AG (DE), Fujifilm Irvine Scientific (US)
Segments Covered Lab Automation Type, Product Type
Key Market Opportunities Integration of artificial intelligence in Automated Cell Culture Equipment enhances efficiency and precision in research applications.
Key Market Dynamics Technological advancements drive innovation in automated cell culture equipment, enhancing efficiency and scalability in research applications.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the projected market valuation of the Automated Cell Culture Equipment Market by 2035?

<p>The market is projected to reach approximately 2.121 USD Billion by 2035.</p>

What was the market valuation of the Automated Cell Culture Equipment Market in 2024?

<p>The market valuation was 0.97 USD Billion in 2024.</p>

What is the expected CAGR for the Automated Cell Culture Equipment Market from 2025 to 2035?

<p>The expected CAGR during the forecast period 2025 - 2035 is 7.37%.</p>

Which segment is anticipated to have the highest growth in the Automated Cell Culture Equipment Market?

<p>The Modular Automation segment is expected to grow from 0.58 USD Billion in 2024 to 1.23 USD Billion by 2035.</p>

What are the key product types in the Automated Cell Culture Equipment Market?

<p>Key product types include Consumables, Equipment, and Software, with Equipment projected to grow from 0.45 USD Billion to 1.0 USD Billion by 2035.</p>

Which end-user segment is likely to dominate the Automated Cell Culture Equipment Market?

<p>The Pharmaceutical and Biotechnological Industries are projected to dominate, growing from 0.45 USD Billion in 2024 to 0.95 USD Billion by 2035.</p>

Who are the leading companies in the Automated Cell Culture Equipment Market?

<p>Key players include Thermo Fisher Scientific, Merck KGaA, Corning Incorporated, and Becton, Dickinson and Company.</p>

What applications are driving growth in the Automated Cell Culture Equipment Market?

Applications such as Biopharmaceutical Productions and Vaccine Production are driving growth, with the former expected to rise from 0.25 USD Billion to 0.55 USD Billion by 2035.

How does the Whole Lab Automation segment compare to Modular Automation in terms of market size?

The Whole Lab Automation segment is projected to grow from 0.39 USD Billion in 2024 to 0.89 USD Billion by 2035, indicating substantial growth but less than Modular Automation.

What is the significance of the Automated Cell Culture Equipment Market for research and academic institutes?

Research and Academic Institutes are expected to see growth from 0.12 USD Billion in 2024 to 0.25 USD Billion by 2035, highlighting their increasing reliance on automated solutions.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. | 1.1 EXECUTIVE SUMMARY
    2. | | 1.1.1 Market Overview
    3. | | 1.1.2 Key Findings
    4. | | 1.1.3 Market Segmentation
    5. | | 1.1.4 Competitive Landscape
    6. | | 1.1.5 Challenges and Opportunities
    7. | | 1.1.6 Future Outlook
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. | 2.1 MARKET INTRODUCTION
    2. | | 2.1.1 Definition
    3. | | 2.1.2 Scope of the study
    4. | | | 2.1.2.1 Research Objective
    5. | | | 2.1.2.2 Assumption
    6. | | | 2.1.2.3 Limitations
    7. | 2.2 RESEARCH METHODOLOGY
    8. | | 2.2.1 Overview
    9. | | 2.2.2 Data Mining
    10. | | 2.2.3 Secondary Research
    11. | | 2.2.4 Primary Research
    12. | | | 2.2.4.1 Primary Interviews and Information Gathering Process
    13. | | | 2.2.4.2 Breakdown of Primary Respondents
    14. | | 2.2.5 Forecasting Model
    15. | | 2.2.6 Market Size Estimation
    16. | | | 2.2.6.1 Bottom-Up Approach
    17. | | | 2.2.6.2 Top-Down Approach
    18. | | 2.2.7 Data Triangulation
    19. | | 2.2.8 Validation
  3. SECTION III: QUALITATIVE ANALYSIS
    1. | 3.1 MARKET DYNAMICS
    2. | | 3.1.1 Overview
    3. | | 3.1.2 Drivers
    4. | | 3.1.3 Restraints
    5. | | 3.1.4 Opportunities
    6. | 3.2 MARKET FACTOR ANALYSIS
    7. | | 3.2.1 Value chain Analysis
    8. | | 3.2.2 Porter's Five Forces Analysis
    9. | | | 3.2.2.1 Bargaining Power of Suppliers
    10. | | | 3.2.2.2 Bargaining Power of Buyers
    11. | | | 3.2.2.3 Threat of New Entrants
    12. | | | 3.2.2.4 Threat of Substitutes
    13. | | | 3.2.2.5 Intensity of Rivalry
    14. | | 3.2.3 COVID-19 Impact Analysis
    15. | | | 3.2.3.1 Market Impact Analysis
    16. | | | 3.2.3.2 Regional Impact
    17. | | | 3.2.3.3 Opportunity and Threat Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. | 4.1 Healthcare, BY Lab Automation Type (USD Billion)
    2. | | 4.1.1 Modular Automation
    3. | | 4.1.2 Whole Lab Automation
    4. | 4.2 Healthcare, BY Product Type (USD Billion)
    5. | | 4.2.1 Consumables
    6. | | 4.2.2 Equipment
    7. | | 4.2.3 Software
    8. | 4.3 Healthcare, BY Application (USD Billion)
    9. | | 4.3.1 Biopharmaceutical Productions
    10. | | 4.3.2 Vaccine Production
    11. | | 4.3.3 Tissue Engineering
    12. | | 4.3.4 Stem Cell Therapy
    13. | | 4.3.5 Toxicity Testing
    14. | | 4.3.6 General Diagnosis
    15. | | 4.3.7 Drug Screening and Development
    16. | 4.4 Healthcare, BY End-User (USD Billion)
    17. | | 4.4.1 Pharmaceutical and Biotechnological Industries
    18. | | 4.4.2 Hospitals and Diagnostic Labs
    19. | | 4.4.3 Pathological Labs
    20. | | 4.4.4 Research and Academic Institutes
    21. | 4.5 Healthcare, BY Region (USD Billion)
    22. | | 4.5.1 North America
    23. | | | 4.5.1.1 US
    24. | | | 4.5.1.2 Canada
    25. | | 4.5.2 Europe
    26. | | | 4.5.2.1 Germany
    27. | | | 4.5.2.2 UK
    28. | | | 4.5.2.3 France
    29. | | | 4.5.2.4 Russia
    30. | | | 4.5.2.5 Italy
    31. | | | 4.5.2.6 Spain
    32. | | | 4.5.2.7 Rest of Europe
    33. | | 4.5.3 APAC
    34. | | | 4.5.3.1 China
    35. | | | 4.5.3.2 India
    36. | | | 4.5.3.3 Japan
    37. | | | 4.5.3.4 South Korea
    38. | | | 4.5.3.5 Malaysia
    39. | | | 4.5.3.6 Thailand
    40. | | | 4.5.3.7 Indonesia
    41. | | | 4.5.3.8 Rest of APAC
    42. | | 4.5.4 South America
    43. | | | 4.5.4.1 Brazil
    44. | | | 4.5.4.2 Mexico
    45. | | | 4.5.4.3 Argentina
    46. | | | 4.5.4.4 Rest of South America
    47. | | 4.5.5 MEA
    48. | | | 4.5.5.1 GCC Countries
    49. | | | 4.5.5.2 South Africa
    50. | | | 4.5.5.3 Rest of MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. | 5.1 Competitive Landscape
    2. | | 5.1.1 Overview
    3. | | 5.1.2 Competitive Analysis
    4. | | 5.1.3 Market share Analysis
    5. | | 5.1.4 Major Growth Strategy in the Healthcare
    6. | | 5.1.5 Competitive Benchmarking
    7. | | 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
    8. | | 5.1.7 Key developments and growth strategies
    9. | | | 5.1.7.1 New Product Launch/Service Deployment
    10. | | | 5.1.7.2 Merger & Acquisitions
    11. | | | 5.1.7.3 Joint Ventures
    12. | | 5.1.8 Major Players Financial Matrix
    13. | | | 5.1.8.1 Sales and Operating Income
    14. | | | 5.1.8.2 Major Players R&D Expenditure. 2023
    15. | 5.2 Company Profiles
    16. | | 5.2.1 Thermo Fisher Scientific (US)
    17. | | | 5.2.1.1 Financial Overview
    18. | | | 5.2.1.2 Products Offered
    19. | | | 5.2.1.3 Key Developments
    20. | | | 5.2.1.4 SWOT Analysis
    21. | | | 5.2.1.5 Key Strategies
    22. | | 5.2.2 Merck KGaA (DE)
    23. | | | 5.2.2.1 Financial Overview
    24. | | | 5.2.2.2 Products Offered
    25. | | | 5.2.2.3 Key Developments
    26. | | | 5.2.2.4 SWOT Analysis
    27. | | | 5.2.2.5 Key Strategies
    28. | | 5.2.3 Corning Incorporated (US)
    29. | | | 5.2.3.1 Financial Overview
    30. | | | 5.2.3.2 Products Offered
    31. | | | 5.2.3.3 Key Developments
    32. | | | 5.2.3.4 SWOT Analysis
    33. | | | 5.2.3.5 Key Strategies
    34. | | 5.2.4 Becton, Dickinson and Company (US)
    35. | | | 5.2.4.1 Financial Overview
    36. | | | 5.2.4.2 Products Offered
    37. | | | 5.2.4.3 Key Developments
    38. | | | 5.2.4.4 SWOT Analysis
    39. | | | 5.2.4.5 Key Strategies
    40. | | 5.2.5 Lonza Group AG (CH)
    41. | | | 5.2.5.1 Financial Overview
    42. | | | 5.2.5.2 Products Offered
    43. | | | 5.2.5.3 Key Developments
    44. | | | 5.2.5.4 SWOT Analysis
    45. | | | 5.2.5.5 Key Strategies
    46. | | 5.2.6 GE Healthcare (US)
    47. | | | 5.2.6.1 Financial Overview
    48. | | | 5.2.6.2 Products Offered
    49. | | | 5.2.6.3 Key Developments
    50. | | | 5.2.6.4 SWOT Analysis
    51. | | | 5.2.6.5 Key Strategies
    52. | | 5.2.7 Sartorius AG (DE)
    53. | | | 5.2.7.1 Financial Overview
    54. | | | 5.2.7.2 Products Offered
    55. | | | 5.2.7.3 Key Developments
    56. | | | 5.2.7.4 SWOT Analysis
    57. | | | 5.2.7.5 Key Strategies
    58. | | 5.2.8 Eppendorf AG (DE)
    59. | | | 5.2.8.1 Financial Overview
    60. | | | 5.2.8.2 Products Offered
    61. | | | 5.2.8.3 Key Developments
    62. | | | 5.2.8.4 SWOT Analysis
    63. | | | 5.2.8.5 Key Strategies
    64. | | 5.2.9 Fujifilm Irvine Scientific (US)
    65. | | | 5.2.9.1 Financial Overview
    66. | | | 5.2.9.2 Products Offered
    67. | | | 5.2.9.3 Key Developments
    68. | | | 5.2.9.4 SWOT Analysis
    69. | | | 5.2.9.5 Key Strategies
    70. | 5.3 Appendix
    71. | | 5.3.1 References
    72. | | 5.3.2 Related Reports
  6. LIST OF FIGURES
    1. | 6.1 MARKET SYNOPSIS
    2. | 6.2 NORTH AMERICA MARKET ANALYSIS
    3. | 6.3 US MARKET ANALYSIS BY LAB AUTOMATION TYPE
    4. | 6.4 US MARKET ANALYSIS BY PRODUCT TYPE
    5. | 6.5 US MARKET ANALYSIS BY APPLICATION
    6. | 6.6 US MARKET ANALYSIS BY END-USER
    7. | 6.7 CANADA MARKET ANALYSIS BY LAB AUTOMATION TYPE
    8. | 6.8 CANADA MARKET ANALYSIS BY PRODUCT TYPE
    9. | 6.9 CANADA MARKET ANALYSIS BY APPLICATION
    10. | 6.10 CANADA MARKET ANALYSIS BY END-USER
    11. | 6.11 EUROPE MARKET ANALYSIS
    12. | 6.12 GERMANY MARKET ANALYSIS BY LAB AUTOMATION TYPE
    13. | 6.13 GERMANY MARKET ANALYSIS BY PRODUCT TYPE
    14. | 6.14 GERMANY MARKET ANALYSIS BY APPLICATION
    15. | 6.15 GERMANY MARKET ANALYSIS BY END-USER
    16. | 6.16 UK MARKET ANALYSIS BY LAB AUTOMATION TYPE
    17. | 6.17 UK MARKET ANALYSIS BY PRODUCT TYPE
    18. | 6.18 UK MARKET ANALYSIS BY APPLICATION
    19. | 6.19 UK MARKET ANALYSIS BY END-USER
    20. | 6.20 FRANCE MARKET ANALYSIS BY LAB AUTOMATION TYPE
    21. | 6.21 FRANCE MARKET ANALYSIS BY PRODUCT TYPE
    22. | 6.22 FRANCE MARKET ANALYSIS BY APPLICATION
    23. | 6.23 FRANCE MARKET ANALYSIS BY END-USER
    24. | 6.24 RUSSIA MARKET ANALYSIS BY LAB AUTOMATION TYPE
    25. | 6.25 RUSSIA MARKET ANALYSIS BY PRODUCT TYPE
    26. | 6.26 RUSSIA MARKET ANALYSIS BY APPLICATION
    27. | 6.27 RUSSIA MARKET ANALYSIS BY END-USER
    28. | 6.28 ITALY MARKET ANALYSIS BY LAB AUTOMATION TYPE
    29. | 6.29 ITALY MARKET ANALYSIS BY PRODUCT TYPE
    30. | 6.30 ITALY MARKET ANALYSIS BY APPLICATION
    31. | 6.31 ITALY MARKET ANALYSIS BY END-USER
    32. | 6.32 SPAIN MARKET ANALYSIS BY LAB AUTOMATION TYPE
    33. | 6.33 SPAIN MARKET ANALYSIS BY PRODUCT TYPE
    34. | 6.34 SPAIN MARKET ANALYSIS BY APPLICATION
    35. | 6.35 SPAIN MARKET ANALYSIS BY END-USER
    36. | 6.36 REST OF EUROPE MARKET ANALYSIS BY LAB AUTOMATION TYPE
    37. | 6.37 REST OF EUROPE MARKET ANALYSIS BY PRODUCT TYPE
    38. | 6.38 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
    39. | 6.39 REST OF EUROPE MARKET ANALYSIS BY END-USER
    40. | 6.40 APAC MARKET ANALYSIS
    41. | 6.41 CHINA MARKET ANALYSIS BY LAB AUTOMATION TYPE
    42. | 6.42 CHINA MARKET ANALYSIS BY PRODUCT TYPE
    43. | 6.43 CHINA MARKET ANALYSIS BY APPLICATION
    44. | 6.44 CHINA MARKET ANALYSIS BY END-USER
    45. | 6.45 INDIA MARKET ANALYSIS BY LAB AUTOMATION TYPE
    46. | 6.46 INDIA MARKET ANALYSIS BY PRODUCT TYPE
    47. | 6.47 INDIA MARKET ANALYSIS BY APPLICATION
    48. | 6.48 INDIA MARKET ANALYSIS BY END-USER
    49. | 6.49 JAPAN MARKET ANALYSIS BY LAB AUTOMATION TYPE
    50. | 6.50 JAPAN MARKET ANALYSIS BY PRODUCT TYPE
    51. | 6.51 JAPAN MARKET ANALYSIS BY APPLICATION
    52. | 6.52 JAPAN MARKET ANALYSIS BY END-USER
    53. | 6.53 SOUTH KOREA MARKET ANALYSIS BY LAB AUTOMATION TYPE
    54. | 6.54 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE
    55. | 6.55 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    56. | 6.56 SOUTH KOREA MARKET ANALYSIS BY END-USER
    57. | 6.57 MALAYSIA MARKET ANALYSIS BY LAB AUTOMATION TYPE
    58. | 6.58 MALAYSIA MARKET ANALYSIS BY PRODUCT TYPE
    59. | 6.59 MALAYSIA MARKET ANALYSIS BY APPLICATION
    60. | 6.60 MALAYSIA MARKET ANALYSIS BY END-USER
    61. | 6.61 THAILAND MARKET ANALYSIS BY LAB AUTOMATION TYPE
    62. | 6.62 THAILAND MARKET ANALYSIS BY PRODUCT TYPE
    63. | 6.63 THAILAND MARKET ANALYSIS BY APPLICATION
    64. | 6.64 THAILAND MARKET ANALYSIS BY END-USER
    65. | 6.65 INDONESIA MARKET ANALYSIS BY LAB AUTOMATION TYPE
    66. | 6.66 INDONESIA MARKET ANALYSIS BY PRODUCT TYPE
    67. | 6.67 INDONESIA MARKET ANALYSIS BY APPLICATION
    68. | 6.68 INDONESIA MARKET ANALYSIS BY END-USER
    69. | 6.69 REST OF APAC MARKET ANALYSIS BY LAB AUTOMATION TYPE
    70. | 6.70 REST OF APAC MARKET ANALYSIS BY PRODUCT TYPE
    71. | 6.71 REST OF APAC MARKET ANALYSIS BY APPLICATION
    72. | 6.72 REST OF APAC MARKET ANALYSIS BY END-USER
    73. | 6.73 SOUTH AMERICA MARKET ANALYSIS
    74. | 6.74 BRAZIL MARKET ANALYSIS BY LAB AUTOMATION TYPE
    75. | 6.75 BRAZIL MARKET ANALYSIS BY PRODUCT TYPE
    76. | 6.76 BRAZIL MARKET ANALYSIS BY APPLICATION
    77. | 6.77 BRAZIL MARKET ANALYSIS BY END-USER
    78. | 6.78 MEXICO MARKET ANALYSIS BY LAB AUTOMATION TYPE
    79. | 6.79 MEXICO MARKET ANALYSIS BY PRODUCT TYPE
    80. | 6.80 MEXICO MARKET ANALYSIS BY APPLICATION
    81. | 6.81 MEXICO MARKET ANALYSIS BY END-USER
    82. | 6.82 ARGENTINA MARKET ANALYSIS BY LAB AUTOMATION TYPE
    83. | 6.83 ARGENTINA MARKET ANALYSIS BY PRODUCT TYPE
    84. | 6.84 ARGENTINA MARKET ANALYSIS BY APPLICATION
    85. | 6.85 ARGENTINA MARKET ANALYSIS BY END-USER
    86. | 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY LAB AUTOMATION TYPE
    87. | 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE
    88. | 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    89. | 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USER
    90. | 6.90 MEA MARKET ANALYSIS
    91. | 6.91 GCC COUNTRIES MARKET ANALYSIS BY LAB AUTOMATION TYPE
    92. | 6.92 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT TYPE
    93. | 6.93 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
    94. | 6.94 GCC COUNTRIES MARKET ANALYSIS BY END-USER
    95. | 6.95 SOUTH AFRICA MARKET ANALYSIS BY LAB AUTOMATION TYPE
    96. | 6.96 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT TYPE
    97. | 6.97 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
    98. | 6.98 SOUTH AFRICA MARKET ANALYSIS BY END-USER
    99. | 6.99 REST OF MEA MARKET ANALYSIS BY LAB AUTOMATION TYPE
    100. | 6.100 REST OF MEA MARKET ANALYSIS BY PRODUCT TYPE
    101. | 6.101 REST OF MEA MARKET ANALYSIS BY APPLICATION
    102. | 6.102 REST OF MEA MARKET ANALYSIS BY END-USER
    103. | 6.103 KEY BUYING CRITERIA OF HEALTHCARE
    104. | 6.104 RESEARCH PROCESS OF MRFR
    105. | 6.105 DRO ANALYSIS OF HEALTHCARE
    106. | 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    107. | 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    108. | 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
    109. | 6.109 HEALTHCARE, BY LAB AUTOMATION TYPE, 2024 (% SHARE)
    110. | 6.110 HEALTHCARE, BY LAB AUTOMATION TYPE, 2024 TO 2035 (USD Billion)
    111. | 6.111 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
    112. | 6.112 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
    113. | 6.113 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    114. | 6.114 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    115. | 6.115 HEALTHCARE, BY END-USER, 2024 (% SHARE)
    116. | 6.116 HEALTHCARE, BY END-USER, 2024 TO 2035 (USD Billion)
    117. | 6.117 BENCHMARKING OF MAJOR COMPETITORS
  7. LIST OF TABLES
    1. | 7.1 LIST OF ASSUMPTIONS
    2. | | 7.1.1
    3. | 7.2 North America MARKET SIZE ESTIMATES; FORECAST
    4. | | 7.2.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    5. | | 7.2.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    6. | | 7.2.3 BY APPLICATION, 2025-2035 (USD Billion)
    7. | | 7.2.4 BY END-USER, 2025-2035 (USD Billion)
    8. | 7.3 US MARKET SIZE ESTIMATES; FORECAST
    9. | | 7.3.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    10. | | 7.3.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    11. | | 7.3.3 BY APPLICATION, 2025-2035 (USD Billion)
    12. | | 7.3.4 BY END-USER, 2025-2035 (USD Billion)
    13. | 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
    14. | | 7.4.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    15. | | 7.4.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    16. | | 7.4.3 BY APPLICATION, 2025-2035 (USD Billion)
    17. | | 7.4.4 BY END-USER, 2025-2035 (USD Billion)
    18. | 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
    19. | | 7.5.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    20. | | 7.5.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    21. | | 7.5.3 BY APPLICATION, 2025-2035 (USD Billion)
    22. | | 7.5.4 BY END-USER, 2025-2035 (USD Billion)
    23. | 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
    24. | | 7.6.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    25. | | 7.6.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    26. | | 7.6.3 BY APPLICATION, 2025-2035 (USD Billion)
    27. | | 7.6.4 BY END-USER, 2025-2035 (USD Billion)
    28. | 7.7 UK MARKET SIZE ESTIMATES; FORECAST
    29. | | 7.7.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    30. | | 7.7.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    31. | | 7.7.3 BY APPLICATION, 2025-2035 (USD Billion)
    32. | | 7.7.4 BY END-USER, 2025-2035 (USD Billion)
    33. | 7.8 France MARKET SIZE ESTIMATES; FORECAST
    34. | | 7.8.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    35. | | 7.8.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    36. | | 7.8.3 BY APPLICATION, 2025-2035 (USD Billion)
    37. | | 7.8.4 BY END-USER, 2025-2035 (USD Billion)
    38. | 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
    39. | | 7.9.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    40. | | 7.9.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    41. | | 7.9.3 BY APPLICATION, 2025-2035 (USD Billion)
    42. | | 7.9.4 BY END-USER, 2025-2035 (USD Billion)
    43. | 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
    44. | | 7.10.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    45. | | 7.10.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    46. | | 7.10.3 BY APPLICATION, 2025-2035 (USD Billion)
    47. | | 7.10.4 BY END-USER, 2025-2035 (USD Billion)
    48. | 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
    49. | | 7.11.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    50. | | 7.11.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    51. | | 7.11.3 BY APPLICATION, 2025-2035 (USD Billion)
    52. | | 7.11.4 BY END-USER, 2025-2035 (USD Billion)
    53. | 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
    54. | | 7.12.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    55. | | 7.12.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    56. | | 7.12.3 BY APPLICATION, 2025-2035 (USD Billion)
    57. | | 7.12.4 BY END-USER, 2025-2035 (USD Billion)
    58. | 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
    59. | | 7.13.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    60. | | 7.13.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    61. | | 7.13.3 BY APPLICATION, 2025-2035 (USD Billion)
    62. | | 7.13.4 BY END-USER, 2025-2035 (USD Billion)
    63. | 7.14 China MARKET SIZE ESTIMATES; FORECAST
    64. | | 7.14.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    65. | | 7.14.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    66. | | 7.14.3 BY APPLICATION, 2025-2035 (USD Billion)
    67. | | 7.14.4 BY END-USER, 2025-2035 (USD Billion)
    68. | 7.15 India MARKET SIZE ESTIMATES; FORECAST
    69. | | 7.15.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    70. | | 7.15.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    71. | | 7.15.3 BY APPLICATION, 2025-2035 (USD Billion)
    72. | | 7.15.4 BY END-USER, 2025-2035 (USD Billion)
    73. | 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
    74. | | 7.16.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    75. | | 7.16.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    76. | | 7.16.3 BY APPLICATION, 2025-2035 (USD Billion)
    77. | | 7.16.4 BY END-USER, 2025-2035 (USD Billion)
    78. | 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
    79. | | 7.17.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    80. | | 7.17.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    81. | | 7.17.3 BY APPLICATION, 2025-2035 (USD Billion)
    82. | | 7.17.4 BY END-USER, 2025-2035 (USD Billion)
    83. | 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
    84. | | 7.18.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    85. | | 7.18.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    86. | | 7.18.3 BY APPLICATION, 2025-2035 (USD Billion)
    87. | | 7.18.4 BY END-USER, 2025-2035 (USD Billion)
    88. | 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
    89. | | 7.19.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    90. | | 7.19.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    91. | | 7.19.3 BY APPLICATION, 2025-2035 (USD Billion)
    92. | | 7.19.4 BY END-USER, 2025-2035 (USD Billion)
    93. | 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
    94. | | 7.20.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    95. | | 7.20.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    96. | | 7.20.3 BY APPLICATION, 2025-2035 (USD Billion)
    97. | | 7.20.4 BY END-USER, 2025-2035 (USD Billion)
    98. | 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
    99. | | 7.21.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    100. | | 7.21.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    101. | | 7.21.3 BY APPLICATION, 2025-2035 (USD Billion)
    102. | | 7.21.4 BY END-USER, 2025-2035 (USD Billion)
    103. | 7.22 South America MARKET SIZE ESTIMATES; FORECAST
    104. | | 7.22.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    105. | | 7.22.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    106. | | 7.22.3 BY APPLICATION, 2025-2035 (USD Billion)
    107. | | 7.22.4 BY END-USER, 2025-2035 (USD Billion)
    108. | 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
    109. | | 7.23.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    110. | | 7.23.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    111. | | 7.23.3 BY APPLICATION, 2025-2035 (USD Billion)
    112. | | 7.23.4 BY END-USER, 2025-2035 (USD Billion)
    113. | 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
    114. | | 7.24.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    115. | | 7.24.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    116. | | 7.24.3 BY APPLICATION, 2025-2035 (USD Billion)
    117. | | 7.24.4 BY END-USER, 2025-2035 (USD Billion)
    118. | 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
    119. | | 7.25.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    120. | | 7.25.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    121. | | 7.25.3 BY APPLICATION, 2025-2035 (USD Billion)
    122. | | 7.25.4 BY END-USER, 2025-2035 (USD Billion)
    123. | 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
    124. | | 7.26.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    125. | | 7.26.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    126. | | 7.26.3 BY APPLICATION, 2025-2035 (USD Billion)
    127. | | 7.26.4 BY END-USER, 2025-2035 (USD Billion)
    128. | 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
    129. | | 7.27.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    130. | | 7.27.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    131. | | 7.27.3 BY APPLICATION, 2025-2035 (USD Billion)
    132. | | 7.27.4 BY END-USER, 2025-2035 (USD Billion)
    133. | 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
    134. | | 7.28.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    135. | | 7.28.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    136. | | 7.28.3 BY APPLICATION, 2025-2035 (USD Billion)
    137. | | 7.28.4 BY END-USER, 2025-2035 (USD Billion)
    138. | 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
    139. | | 7.29.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    140. | | 7.29.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    141. | | 7.29.3 BY APPLICATION, 2025-2035 (USD Billion)
    142. | | 7.29.4 BY END-USER, 2025-2035 (USD Billion)
    143. | 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
    144. | | 7.30.1 BY LAB AUTOMATION TYPE, 2025-2035 (USD Billion)
    145. | | 7.30.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    146. | | 7.30.3 BY APPLICATION, 2025-2035 (USD Billion)
    147. | | 7.30.4 BY END-USER, 2025-2035 (USD Billion)
    148. | 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    149. | | 7.31.1
    150. | 7.32 ACQUISITION/PARTNERSHIP
    151. | | 7.32.1

Healthcare Market Segmentation

Healthcare By Lab Automation Type (USD Billion, 2025-2035)

  • Modular Automation
  • Whole Lab Automation

Healthcare By Product Type (USD Billion, 2025-2035)

  • Consumables
  • Equipment
  • Software

Healthcare By Application (USD Billion, 2025-2035)

  • Biopharmaceutical Productions
  • Vaccine Production
  • Tissue Engineering
  • Stem Cell Therapy
  • Toxicity Testing
  • General Diagnosis
  • Drug Screening and Development

Healthcare By End-User (USD Billion, 2025-2035)

  • Pharmaceutical and Biotechnological Industries
  • Hospitals and Diagnostic Labs
  • Pathological Labs
  • Research and Academic Institutes
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓